Literature DB >> 10385673

An infectious molecular clone of a Japanese genotype 1b hepatitis C virus.

M R Beard1, G Abell, M Honda, A Carroll, M Gartland, B Clarke, K Suzuki, R Lanford, D V Sangar, S M Lemon.   

Abstract

We describe an infectious molecular clone of a Japanese genotype 1b strain of hepatitis C virus (HCV-N). The molecularly cloned sequence of HCV-N was compared with alignments of other HCV sequences, leading to the identification of 15 unique, nonconservative amino acid substitutions within the HCV-N open reading frame (ORF). These were repaired to the consensus genotype 1b residue, and the infectivity of RNA transcribed from the repaired clone was assessed by intrahepatic inoculation of a chimpanzee. Viral RNA was first detected in the serum of this chimpanzee 3 weeks following inoculation, and was intermittently present over the next 14 weeks. A strong and persistent anti-HCV serological response developed 13 weeks following inoculation, with seroconversion in the recombinant immunoblot assay (RIBA). A weaker, transient serological response, characterized by seroconversion in a third-generation enzyme-linked immunosorbent assay (ELISA) but not RIBA, occurred between weeks 1 and 5. This may have represented an anamnestic response to HCV antigens translated directly from the intrahepatically inoculated RNA, because the animal previously had undergone 2 unsuccessful attempts at rescue of HCV by intrahepatic RNA inoculation. There was neither biochemical nor histological evidence of liver disease. Although this is within the range of expected outcomes in an HCV-naive chimpanzee, prior immunologic priming may have modified the infection in this animal. The HCV-N clone is the first infectious molecular clone of HCV that is comprised entirely of genotype 1b sequence, and it contains an ORF sequence that is significantly divergent from that of a previously described genotype 1a/1b chimera.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385673     DOI: 10.1002/hep.510300137

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  49 in total

1.  The science, economics, and effectiveness of combination therapy for hepatitis C.

Authors:  G Dusheiko; E Barnes; G Webster; S Whalley
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

2.  Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame.

Authors:  J L Walewski; T R Keller; D D Stump; A D Branch
Journal:  RNA       Date:  2001-05       Impact factor: 4.942

3.  Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus.

Authors:  B Beames; D Chavez; B Guerra; L Notvall; K M Brasky; R E Lanford
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

4.  TRIM56 is a virus- and interferon-inducible E3 ubiquitin ligase that restricts pestivirus infection.

Authors:  Jie Wang; Baoming Liu; Nan Wang; Young-Min Lee; Chunming Liu; Kui Li
Journal:  J Virol       Date:  2011-02-02       Impact factor: 5.103

Review 5.  Cell culture systems for the hepatitis C virus.

Authors:  Gilles Duverlie; Czeslaw Wychowski
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

6.  Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice.

Authors:  Mayura M Desai; Batbayar Tumurbataar; Yueqing Zhang; Lee-Nien Lillian Chan; Jiaren Sun; Teh-Sheng Chan
Journal:  Transgenic Res       Date:  2011-02-24       Impact factor: 2.788

7.  Self-assembly of nucleocapsid-like particles from recombinant hepatitis C virus core protein.

Authors:  M Kunkel; M Lorinczi; R Rijnbrand; S M Lemon; S J Watowich
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

8.  Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells.

Authors:  MinKyung Yi; Stanley M Lemon
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation.

Authors:  Jin Ye; Chunfu Wang; Rhea Sumpter; Michael S Brown; Joseph L Goldstein; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

10.  Intramembrane proteolysis promotes trafficking of hepatitis C virus core protein to lipid droplets.

Authors:  John McLauchlan; Marius K Lemberg; Graham Hope; Bruno Martoglio
Journal:  EMBO J       Date:  2002-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.